查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
抗肥胖药物全球市场规模、份额、行业趋势分析报告：药物类型、作用机制、给药途径（口服、皮下）、分销渠道、区域展望和预测，2023-2029 年
市场调查报告书
商品编码
1276667

抗肥胖药物全球市场规模、份额、行业趋势分析报告：药物类型、作用机制、给药途径（口服、皮下）、分销渠道、区域展望和预测，2023-2029 年

Global Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2029
出版日期: | 出版商: KBV Research | 英文 220 Pages | 订单完成后即时交付

价格

预计在预测期内，抗肥胖药物市场规模将以 10.6% 的复合年增长率增长，到 2029 年将达到 31 亿美元。

肥胖治疗临床研究的扩展预计将推动抗肥胖药物的需求。 例如，大公司正在开发有前途的药物替代品，以增强肥胖症治疗方案。 预计将推动抗肥胖药物市场份额增长的主要原因之一是主要公司增加了研发活动，以开发副作用更少的抗肥胖药物。

随着肥胖率上升，市场参与者也在开发新产品并获得市场认可。 由于对长效药物的需求不断增加，预计市场供应商创造新产品的机会将大大增加。 随着 2 型糖尿病和肥胖症患病率的上升，许多行业专家和供应商正在研究可以同时治疗这两种疾病的药物。 随着时间的推移，这方面有望支持市场扩张。

COVID-19 影响分析

越来越多地使用远程医疗来代替“面对面”的医院就诊以及使用互联网药店重复购买处方药，从而减轻了对市场的负面影响。 此外，製药公司正在努力在大流行期间保持供需低迷以维持利润。 COVID-19 病毒导致在家工作或在家工作时体重迅速增加，增加了对抗肥胖药物的需求。 还预计即将推出的产品、知名公司的主要管线以及肥胖症的持续上升将导致 COVID-19 后的市场增长潜力显着，导致开局下降。但是，COVID-19 后-19年期有望出现明显增长。

市场增长因素

快餐业的发展和不健康食品消费的增加

快餐业的消费量正在显着增加。 经常吃快餐与肥胖和过敏有关。 由于存在毒素、化学物质和过量的盐分，食用快餐会增加患腹胀、胃溃疡和潜在胃癌等健康问题的风险。 从快餐中摄入的盐分增加会导致体内水分滞留，从而导致胃痛和腹胀等不适症状。 成人快餐消费与财富呈正相关，随着年龄的增长呈负相关。 因此，抗肥胖药物的需求正在增加，市场有望增长。

促进药物研发

为了使新药产生长期利润，公司在各个地区实施的定价策略、该价格下的预期销量以及药物开发过程的成功概率很重要，并且具有对研发成本有很大影响。 此外，政府制度和政策对製药公司的私人研发支出有重大影响。 这种影响是通过多种方法实现的，包括增加对处方药的需求、资助基础研究、监督临床试验以及发布影响供需双方的疫苗指南。

市场製约因素

缺乏对药物治疗的认识和采用

随着客户、设备和服务供应商、互补行业和公共项目的生态系统不断壮大，健身行业正在迅速发展。 个人越来越重视健身并监控他们的日常生活和习惯。 由于全球化和知识的便捷获取，健身行业正在不断发展并变得更加活跃。 这加强和加强了传统的做法和运动。 此外，由于对减肥药的认知度较低，普通大众更喜欢健身房和其他自然减肥方法，这预计会阻碍预测期内减肥药市场的增长。

药物类型展望

按药物类型划分，抗肥胖药市场分为处方药和非处方药 (OTC)。 处方药板块在 2022 年以最大的收入份额主导了抗肥胖药物市场。 这种增长归因于现有企业的产品获得监管批准。 这些公司正在通过增加对研发计划的投资和结成战略联盟来将有效的治疗药物推向市场，从而推动这些产品的采用。

作用机制展望

抗肥胖药物市场按作用机制分为中枢作用抗肥胖药物和外周作用抗肥胖药物。 到 2022 年，外周作用部分在抗肥胖药物市场中占据了重要的收入份额。 这是因为外周作用抗肥胖药物是指在不影响大脑或食慾控制的情况下帮助减轻体重的药物。 本品作为胰脂肪□抑製剂，有效抑制脂肪在胃肠道内的分解，最终导致脂肪在肠道内的吸收减少。

管理路线展望

按给药途径，抗肥胖药市场分为口服给药和皮下给药。 到 2022 年，口服给药部分在抗肥胖药物市场中占据最大的收入份额。 这是因为口服药物递送是抗肥胖药物的首选给药途径，因为它具有非侵入性、患者依从性高、易于处理和缺乏特定的无菌性。 各种类型的纳米颗粒 (NP)、水凝胶、微粒或其组合已被用于提高肠道中的生物利用度或靶向特异性。

分销渠道展望

根据分销渠道，抗肥胖药市场分为医院药店、零售药店和在线药店。 2022 年，在线药店业务在减肥药市场中占据了很大的收入份额。 这是由于电子药房的使用增加、患者更容易获得抗肥胖药物以及简化的药物采购流程。 此外，肥胖这种慢性疾病需要患者补充药物以维持长期治疗方案。 因此，在预测期内，通过在线药店增加抗肥胖药物的使用可能会推动该细分市场的增长。

区域展望

按地区划分，分析了北美、欧洲、亚太地区和 LAMEA 的抗肥胖药物市场。 北美地区将在 2022 年以最大的收入份额引领抗肥胖药物市场。 该地区减肥药市场的增长主要是由于肥胖人数的增加和减肥药的高医疗支出所推动的。 此外，由于行业巨头增加研发投资，公众对与肥胖相关的严重慢性病的认识不断提高，临床试验激增，预计将推动市场增长。

内容

第一章市场范围与研究方法

  • 市场定义
  • 目的
  • 市场范围
  • 细分
  • 调查方法

第 2 章市场概述

  • 简介
    • 概览
      • 市场构成和情景
  • 影响市场的主要因素
    • 市场驱动因素
    • 市场製约因素

第 3 章全球抗肥胖药物市场：按药物类型分类

  • 全球处方药市场：按地区
  • 全球场外交易（场外交易）市场：按地区

第 4 章全球抗肥胖药物市场：按作用机制

  • 全球中央作用市场：按地区
  • 全球外围表演市场：按地区

第 5 章全球抗肥胖市场：按给药途径

  • 全球口服剂市场：按地区
  • 全球皮下给药市场，按地区

第 6 章全球抗肥胖药物市场：按分销渠道

  • 全球医院药房市场：按地区
  • 全球零售药店市场：按地区
  • 全球在线药店市场：按地区

第 7 章全球抗肥胖药物市场：按地区

  • 北美
    • 北美市场：按国家/地区分类
      • 美国
      • 加拿大
      • 墨西哥
      • 其他北美地区
  • 欧洲
    • 欧洲市场：按国家/地区分类
      • 德国
      • 英国
      • 法国
      • 俄罗斯
      • 西班牙
      • 意大利
      • 其他欧洲地区
  • 亚太地区
    • 亚太市场：按国家/地区分类
      • 中国
      • 日本
      • 印度
      • 韩国
      • 新加坡
      • 马来西亚
      • 其他亚太地区
  • 拉丁美洲/中东/非洲
    • 按国家/地区划分的拉丁美洲/中东/非洲市场
      • 巴西
      • 阿根廷
      • 阿拉伯联合酋长国
      • 沙特阿拉伯
      • 南非
      • 尼日利亚
      • 其他拉丁美洲/中东/非洲地区

第8章 企业简介

  • Pfizer, Inc
  • Boehringer Ingelheim International Gmbh
  • GlaxoSmithKline PLC（GSK）
  • Novo Nordisk A/S
  • Rhythm Pharmaceuticals, Inc
  • Gelesis Holdings Inc（PureTech Health）
  • Currax Pharmaceuticals LLC（Currax Holdings USA LLC）
  • Vivus LLC
  • CHEPLAPHARM Arzneimittel GmbH（Braun Beteiligungs GmbH）
  • KVK Tech, Inc

The Global Anti-Obesity Drugs Market size is expected to reach $3.1 billion by 2029, rising at a market growth of 10.6% CAGR during the forecast period.

Obesity is a medical disease in which the body's extra body fat has built up to the point that it could be harmful to one's health. Carrying a body mass index (BMI) of 30 or more is the standard definition. It is largely acknowledged as the most significant and rapidly expanding public health issue in both industrialized and developing nations. Anti-obesity medications are ones that doctors prescribe to help the overweight. These medications reduce hunger, boost metabolism, or prevent the absorption of fat from meals.

Phentermine, liraglutide, sibutramine, and orlistat, are a few of the anti-obesity medications that are frequently recommended. The significant increase in the prevalence rate of obesity, the rise in the health risks associated with being overweight or obese, and the rise in the volume of research and development operations for multiple potential drug molecules to combat both obesity and type 2 diabetes mellitus by key market players are the main factors driving the growth of the anti-obesity drugs market share.

The expansion of clinical studies for the treatment of obesity is anticipated to fuel demand for anti-obesity medications. For instance, large corporations are creating prospective medicine substitutes to enhance the scenario for treating obesity. One of the main reasons projected to promote the growth of the anti-obesity drug market share is the increase in R&D activity among key players for the creation of anti-obesity treatments with fewer adverse effects.

As the obesity rate rises, the market's leading companies are also creating new products and gaining market acceptance. Due to the rising demand for long-lasting medications, it is anticipated that the opportunities for market vendors to create new products will increase significantly. Numerous industry experts and suppliers have been conducting research on medications that can treat both type II diabetes and obesity as a result of the increased prevalence of the disease. This aspect is anticipated to support market expansion eventually.

COVID-19 Impact Analysis

The negative effects on the market have been reduced by the rising use of telemedicine in place of "in-person" hospital visits and the use of internet pharmacies to buy repeat prescription drugs. Additionally, pharmaceutical firms put a lot of effort into keeping the pandemic's supply and demand in check to sustain their profits. Due to the rapid weight gain people experience when sitting at home or working from home, the sudden development of the COVID-19 virus has later raised the need for anti-obesity treatments. In addition, it is anticipated that forthcoming product launches, major pipeline opportunities at well-known companies, and a continuing rise in obesity will all contribute to the market's significant growth potential in the post COVID-19 period, after facing a decline in the starting phase.

Market Growth Factors

The growth of fast-food industry and increasing consumption of unhealthy food

The fast-food industry has experienced a significant increase in consumption. Frequent consumption of fast food has been associated with obesity and allergies. Consuming fast food can increase the risk of health issues such as bloating, stomach ulcers, and potentially even stomach cancer due to the presence of harmful substances, chemicals, and excessive salt. Increased salt intake from fast food can lead to water retention in the body, potentially causing discomforts such as stomach pain and abdominal bloating. The correlation between fast food consumption among adults and wealth is positive, while it is negative with age. This is expected to increase the demand for anti-obesity drugs, surging the market growth.

Enhancing pharmaceutical research and development

The success of a new pharmaceutical product in generating long-term profits is contingent upon the pricing strategy implemented by companies across various regions, the projected sales volume at those prices, and the probability of a successful drug development process, which significantly impacts research and development expenses. In addition, government programs and policies significantly influence the pharmaceutical industry's private spending for research and development. This impact is achieved through diverse methods, including boosting the need for prescribed medications, financing fundamental research, overseeing clinical trials, and issuing vaccine guidance that impacts both supply and demand.

Market Restraining Factors

Lack of awareness and adoption of medication

The fitness industry is rapidly evolving with a growing ecosystem comprising customers, equipment and service suppliers, complementary sectors, and public programs. There is a growing trend among individuals to prioritize fitness and monitor their daily routines and habits. The fitness industry is evolving and becoming more dynamic due to globalization and the easy accessibility of knowledge. This enhances and reinforces traditional practices and exercises. Also, gyms and other natural ways are being preferred to lose weight by the general population as there is a lack of awareness regarding anti-obesity drugs, which is expected to hinder the anti-obesity drugs market growth during the projected period.

Drug Type Outlook

Based on drug type, the anti-obesity drugs market is segmented into prescription drugs and over the counter drugs. The prescription drugs segment dominated the anti-obesity drugs market with maximum revenue share in 2022. The growth is attributed due to the presence of established players who have obtained regulatory approval for their products. These enterprises are promoting the acceptance for such commodities by enhancing their investment in research and development programs and forming strategic alliances to launch efficient remedies.

Mechanism of Action Outlook

On the basis of mechanism of action, the anti-obesity drugs market is divided into centrally acting anti-obesity drugs and peripherally acting anti-obesity drugs. The peripherally acting segment procured a substantial revenue share in the anti-obesity drugs market in 2022. This is because peripherally acting anti-obesity agents refer to pharmaceuticals that aid in weight reduction without impacting the brain or appetite suppression. This product functions as a pancreatic lipase inhibitor, effectively impeding the breakdown of fat in the gastrointestinal tract and ultimately leading to a reduction in the absorption of fat in the intestines.

Route of Administration Outlook

By route of administration, the anti-obesity drugs market is classified into oral route and subcutaneous route. The oral route segment witnessed the largest revenue share in the anti-obesity drugs market in 2022. This is because oral drug delivery is a highly preferred administration route for the anti-obesity drug due to its noninvasive nature, high patient compliance, ease of handling, and lack of requirement for specific sterile conditions. Various types of nanoparticles (NPs), hydrogels, microparticles, or combinations of them have been employed to enhance bioavailability or target specificity in the gut.

Distribution Channel Outlook

Based on the distribution channel, the anti-obesity drugs market is bifurcated into hospital pharmacies, retail pharmacies and online pharmacies. The online pharmacies segment recorded a significant revenue share in the anti-obesity drugs market in 2022. This is due to the rise in e-pharmacy usage, which has led to greater accessibility of anti-obesity medication for patients, streamlining the drug procurement process. In addition, the chronic condition of obesity requires the patient to obtain a refill in order to maintain the long-term treatment plan. This can lead to increased utilization of anti-obesity medications through online pharmacy distribution channels, driving the segment's growth during the projected period.

Regional Outlook

Region-wise, the anti-obesity drugs market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region led the anti-obesity drugs market by generating the maximum revenue share in 2022. The growth of the anti-obesity drugs market in the region is primarily fueled by the rise in the number of individuals who are obese and the significant healthcare spending on anti-obesity drugs. Moreover, the market growth is anticipated to be driven by the heightened awareness among the populace regarding the grave chronic ailments associated with obesity and the surge in clinical trials due to increased investment by major industry players in research and development endeavors.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Pfizer, Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, Novo Nordisk A/S, Rhythm Pharmaceuticals, Inc., Gelesis Holdings Inc. (PureTech Health), Currax Pharmaceuticals LLC (Currax Holdings USA LLC), Vivus LLC, CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH) and KVK Tech, Inc.

Scope of the Study

Market Segments covered in the Report:

By Drug Type

  • Prescription Drugs
  • Over The Counter Drugs

By Mechanism of Action

  • Centrally Acting
  • Peripherally Acting

By Route Of Administration

  • Oral Route
  • Subcutaneous Route

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Pfizer, Inc.
  • Boehringer Ingelheim International GmbH
  • GlaxoSmithKline PLC
  • Novo Nordisk A/S
  • Rhythm Pharmaceuticals, Inc.
  • Gelesis Holdings Inc. (PureTech Health)
  • Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
  • Vivus LLC
  • CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH)
  • KVK Tech, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Anti-Obesity Drugs Market, by Drug Type
    • 1.4.2 Global Anti-Obesity Drugs Market, by Mechanism of Action
    • 1.4.3 Global Anti-Obesity Drugs Market, by Route Of Administration
    • 1.4.4 Global Anti-Obesity Drugs Market, by Distribution Channel
    • 1.4.5 Global Anti-Obesity Drugs Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition & scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Anti-Obesity Drugs Market by Drug Type

  • 3.1 Global Prescription Drugs Market by Region
  • 3.2 Global Over The Counter Drugs Market by Region

Chapter 4. Global Anti-Obesity Drugs Market by Mechanism of Action

  • 4.1 Global Centrally Acting Market by Region
  • 4.2 Global Peripherally Acting Market by Region

Chapter 5. Global Anti-Obesity Drugs Market by Route Of Administration

  • 5.1 Global Oral Route Market by Region
  • 5.2 Global Subcutaneous Route Market by Region

Chapter 6. Global Anti-Obesity Drugs Market by Distribution Channel

  • 6.1 Global Hospital Pharmacies Market by Region
  • 6.2 Global Retail Pharmacies Market by Region
  • 6.3 Global Online Pharmacies Market by Region

Chapter 7. Global Anti-Obesity Drugs Market by Region

  • 7.1 North America Anti-Obesity Drugs Market
    • 7.1.1 North America Anti-Obesity Drugs Market by Drug Type
      • 7.1.1.1 North America Prescription Drugs Market by Country
      • 7.1.1.2 North America Over The Counter Drugs Market by Country
    • 7.1.2 North America Anti-Obesity Drugs Market by Mechanism of Action
      • 7.1.2.1 North America Centrally Acting Market by Country
      • 7.1.2.2 North America Peripherally Acting Market by Country
    • 7.1.3 North America Anti-Obesity Drugs Market by Route Of Administration
      • 7.1.3.1 North America Oral Route Market by Country
      • 7.1.3.2 North America Subcutaneous Route Market by Country
    • 7.1.4 North America Anti-Obesity Drugs Market by Distribution Channel
      • 7.1.4.1 North America Hospital Pharmacies Market by Country
      • 7.1.4.2 North America Retail Pharmacies Market by Country
      • 7.1.4.3 North America Online Pharmacies Market by Country
    • 7.1.5 North America Anti-Obesity Drugs Market by Country
      • 7.1.5.1 US Anti-Obesity Drugs Market
        • 7.1.5.1.1 US Anti-Obesity Drugs Market by Drug Type
        • 7.1.5.1.2 US Anti-Obesity Drugs Market by Mechanism of Action
        • 7.1.5.1.3 US Anti-Obesity Drugs Market by Route Of Administration
        • 7.1.5.1.4 US Anti-Obesity Drugs Market by Distribution Channel
      • 7.1.5.2 Canada Anti-Obesity Drugs Market
        • 7.1.5.2.1 Canada Anti-Obesity Drugs Market by Drug Type
        • 7.1.5.2.2 Canada Anti-Obesity Drugs Market by Mechanism of Action
        • 7.1.5.2.3 Canada Anti-Obesity Drugs Market by Route Of Administration
        • 7.1.5.2.4 Canada Anti-Obesity Drugs Market by Distribution Channel
      • 7.1.5.3 Mexico Anti-Obesity Drugs Market
        • 7.1.5.3.1 Mexico Anti-Obesity Drugs Market by Drug Type
        • 7.1.5.3.2 Mexico Anti-Obesity Drugs Market by Mechanism of Action
        • 7.1.5.3.3 Mexico Anti-Obesity Drugs Market by Route Of Administration
        • 7.1.5.3.4 Mexico Anti-Obesity Drugs Market by Distribution Channel
      • 7.1.5.4 Rest of North America Anti-Obesity Drugs Market
        • 7.1.5.4.1 Rest of North America Anti-Obesity Drugs Market by Drug Type
        • 7.1.5.4.2 Rest of North America Anti-Obesity Drugs Market by Mechanism of Action
        • 7.1.5.4.3 Rest of North America Anti-Obesity Drugs Market by Route Of Administration
        • 7.1.5.4.4 Rest of North America Anti-Obesity Drugs Market by Distribution Channel
  • 7.2 Europe Anti-Obesity Drugs Market
    • 7.2.1 Europe Anti-Obesity Drugs Market by Drug Type
      • 7.2.1.1 Europe Prescription Drugs Market by Country
      • 7.2.1.2 Europe Over The Counter Drugs Market by Country
    • 7.2.2 Europe Anti-Obesity Drugs Market by Mechanism of Action
      • 7.2.2.1 Europe Centrally Acting Market by Country
      • 7.2.2.2 Europe Peripherally Acting Market by Country
    • 7.2.3 Europe Anti-Obesity Drugs Market by Route Of Administration
      • 7.2.3.1 Europe Oral Route Market by Country
      • 7.2.3.2 Europe Subcutaneous Route Market by Country
    • 7.2.4 Europe Anti-Obesity Drugs Market by Distribution Channel
      • 7.2.4.1 Europe Hospital Pharmacies Market by Country
      • 7.2.4.2 Europe Retail Pharmacies Market by Country
      • 7.2.4.3 Europe Online Pharmacies Market by Country
    • 7.2.5 Europe Anti-Obesity Drugs Market by Country
      • 7.2.5.1 Germany Anti-Obesity Drugs Market
        • 7.2.5.1.1 Germany Anti-Obesity Drugs Market by Drug Type
        • 7.2.5.1.2 Germany Anti-Obesity Drugs Market by Mechanism of Action
        • 7.2.5.1.3 Germany Anti-Obesity Drugs Market by Route Of Administration
        • 7.2.5.1.4 Germany Anti-Obesity Drugs Market by Distribution Channel
      • 7.2.5.2 UK Anti-Obesity Drugs Market
        • 7.2.5.2.1 UK Anti-Obesity Drugs Market by Drug Type
        • 7.2.5.2.2 UK Anti-Obesity Drugs Market by Mechanism of Action
        • 7.2.5.2.3 UK Anti-Obesity Drugs Market by Route Of Administration
        • 7.2.5.2.4 UK Anti-Obesity Drugs Market by Distribution Channel
      • 7.2.5.3 France Anti-Obesity Drugs Market
        • 7.2.5.3.1 France Anti-Obesity Drugs Market by Drug Type
        • 7.2.5.3.2 France Anti-Obesity Drugs Market by Mechanism of Action
        • 7.2.5.3.3 France Anti-Obesity Drugs Market by Route Of Administration
        • 7.2.5.3.4 France Anti-Obesity Drugs Market by Distribution Channel
      • 7.2.5.4 Russia Anti-Obesity Drugs Market
        • 7.2.5.4.1 Russia Anti-Obesity Drugs Market by Drug Type
        • 7.2.5.4.2 Russia Anti-Obesity Drugs Market by Mechanism of Action
        • 7.2.5.4.3 Russia Anti-Obesity Drugs Market by Route Of Administration
        • 7.2.5.4.4 Russia Anti-Obesity Drugs Market by Distribution Channel
      • 7.2.5.5 Spain Anti-Obesity Drugs Market
        • 7.2.5.5.1 Spain Anti-Obesity Drugs Market by Drug Type
        • 7.2.5.5.2 Spain Anti-Obesity Drugs Market by Mechanism of Action
        • 7.2.5.5.3 Spain Anti-Obesity Drugs Market by Route Of Administration
        • 7.2.5.5.4 Spain Anti-Obesity Drugs Market by Distribution Channel
      • 7.2.5.6 Italy Anti-Obesity Drugs Market
        • 7.2.5.6.1 Italy Anti-Obesity Drugs Market by Drug Type
        • 7.2.5.6.2 Italy Anti-Obesity Drugs Market by Mechanism of Action
        • 7.2.5.6.3 Italy Anti-Obesity Drugs Market by Route Of Administration
        • 7.2.5.6.4 Italy Anti-Obesity Drugs Market by Distribution Channel
      • 7.2.5.7 Rest of Europe Anti-Obesity Drugs Market
        • 7.2.5.7.1 Rest of Europe Anti-Obesity Drugs Market by Drug Type
        • 7.2.5.7.2 Rest of Europe Anti-Obesity Drugs Market by Mechanism of Action
        • 7.2.5.7.3 Rest of Europe Anti-Obesity Drugs Market by Route Of Administration
        • 7.2.5.7.4 Rest of Europe Anti-Obesity Drugs Market by Distribution Channel
  • 7.3 Asia Pacific Anti-Obesity Drugs Market
    • 7.3.1 Asia Pacific Anti-Obesity Drugs Market by Drug Type
      • 7.3.1.1 Asia Pacific Prescription Drugs Market by Country
      • 7.3.1.2 Asia Pacific Over The Counter Drugs Market by Country
    • 7.3.2 Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action
      • 7.3.2.1 Asia Pacific Centrally Acting Market by Country
      • 7.3.2.2 Asia Pacific Peripherally Acting Market by Country
    • 7.3.3 Asia Pacific Anti-Obesity Drugs Market by Route Of Administration
      • 7.3.3.1 Asia Pacific Oral Route Market by Country
      • 7.3.3.2 Asia Pacific Subcutaneous Route Market by Country
    • 7.3.4 Asia Pacific Anti-Obesity Drugs Market by Distribution Channel
      • 7.3.4.1 Asia Pacific Hospital Pharmacies Market by Country
      • 7.3.4.2 Asia Pacific Retail Pharmacies Market by Country
      • 7.3.4.3 Asia Pacific Online Pharmacies Market by Country
    • 7.3.5 Asia Pacific Anti-Obesity Drugs Market by Country
      • 7.3.5.1 China Anti-Obesity Drugs Market
        • 7.3.5.1.1 China Anti-Obesity Drugs Market by Drug Type
        • 7.3.5.1.2 China Anti-Obesity Drugs Market by Mechanism of Action
        • 7.3.5.1.3 China Anti-Obesity Drugs Market by Route Of Administration
        • 7.3.5.1.4 China Anti-Obesity Drugs Market by Distribution Channel
      • 7.3.5.2 Japan Anti-Obesity Drugs Market
        • 7.3.5.2.1 Japan Anti-Obesity Drugs Market by Drug Type
        • 7.3.5.2.2 Japan Anti-Obesity Drugs Market by Mechanism of Action
        • 7.3.5.2.3 Japan Anti-Obesity Drugs Market by Route Of Administration
        • 7.3.5.2.4 Japan Anti-Obesity Drugs Market by Distribution Channel
      • 7.3.5.3 India Anti-Obesity Drugs Market
        • 7.3.5.3.1 India Anti-Obesity Drugs Market by Drug Type
        • 7.3.5.3.2 India Anti-Obesity Drugs Market by Mechanism of Action
        • 7.3.5.3.3 India Anti-Obesity Drugs Market by Route Of Administration
        • 7.3.5.3.4 India Anti-Obesity Drugs Market by Distribution Channel
      • 7.3.5.4 South Korea Anti-Obesity Drugs Market
        • 7.3.5.4.1 South Korea Anti-Obesity Drugs Market by Drug Type
        • 7.3.5.4.2 South Korea Anti-Obesity Drugs Market by Mechanism of Action
        • 7.3.5.4.3 South Korea Anti-Obesity Drugs Market by Route Of Administration
        • 7.3.5.4.4 South Korea Anti-Obesity Drugs Market by Distribution Channel
      • 7.3.5.5 Singapore Anti-Obesity Drugs Market
        • 7.3.5.5.1 Singapore Anti-Obesity Drugs Market by Drug Type
        • 7.3.5.5.2 Singapore Anti-Obesity Drugs Market by Mechanism of Action
        • 7.3.5.5.3 Singapore Anti-Obesity Drugs Market by Route Of Administration
        • 7.3.5.5.4 Singapore Anti-Obesity Drugs Market by Distribution Channel
      • 7.3.5.6 Malaysia Anti-Obesity Drugs Market
        • 7.3.5.6.1 Malaysia Anti-Obesity Drugs Market by Drug Type
        • 7.3.5.6.2 Malaysia Anti-Obesity Drugs Market by Mechanism of Action
        • 7.3.5.6.3 Malaysia Anti-Obesity Drugs Market by Route Of Administration
        • 7.3.5.6.4 Malaysia Anti-Obesity Drugs Market by Distribution Channel
      • 7.3.5.7 Rest of Asia Pacific Anti-Obesity Drugs Market
        • 7.3.5.7.1 Rest of Asia Pacific Anti-Obesity Drugs Market by Drug Type
        • 7.3.5.7.2 Rest of Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action
        • 7.3.5.7.3 Rest of Asia Pacific Anti-Obesity Drugs Market by Route Of Administration
        • 7.3.5.7.4 Rest of Asia Pacific Anti-Obesity Drugs Market by Distribution Channel
  • 7.4 LAMEA Anti-Obesity Drugs Market
    • 7.4.1 LAMEA Anti-Obesity Drugs Market by Drug Type
      • 7.4.1.1 LAMEA Prescription Drugs Market by Country
      • 7.4.1.2 LAMEA Over The Counter Drugs Market by Country
    • 7.4.2 LAMEA Anti-Obesity Drugs Market by Mechanism of Action
      • 7.4.2.1 LAMEA Centrally Acting Market by Country
      • 7.4.2.2 LAMEA Peripherally Acting Market by Country
    • 7.4.3 LAMEA Anti-Obesity Drugs Market by Route Of Administration
      • 7.4.3.1 LAMEA Oral Route Market by Country
      • 7.4.3.2 LAMEA Subcutaneous Route Market by Country
    • 7.4.4 LAMEA Anti-Obesity Drugs Market by Distribution Channel
      • 7.4.4.1 LAMEA Hospital Pharmacies Market by Country
      • 7.4.4.2 LAMEA Retail Pharmacies Market by Country
      • 7.4.4.3 LAMEA Online Pharmacies Market by Country
    • 7.4.5 LAMEA Anti-Obesity Drugs Market by Country
      • 7.4.5.1 Brazil Anti-Obesity Drugs Market
        • 7.4.5.1.1 Brazil Anti-Obesity Drugs Market by Drug Type
        • 7.4.5.1.2 Brazil Anti-Obesity Drugs Market by Mechanism of Action
        • 7.4.5.1.3 Brazil Anti-Obesity Drugs Market by Route Of Administration
        • 7.4.5.1.4 Brazil Anti-Obesity Drugs Market by Distribution Channel
      • 7.4.5.2 Argentina Anti-Obesity Drugs Market
        • 7.4.5.2.1 Argentina Anti-Obesity Drugs Market by Drug Type
        • 7.4.5.2.2 Argentina Anti-Obesity Drugs Market by Mechanism of Action
        • 7.4.5.2.3 Argentina Anti-Obesity Drugs Market by Route Of Administration
        • 7.4.5.2.4 Argentina Anti-Obesity Drugs Market by Distribution Channel
      • 7.4.5.3 UAE Anti-Obesity Drugs Market
        • 7.4.5.3.1 UAE Anti-Obesity Drugs Market by Drug Type
        • 7.4.5.3.2 UAE Anti-Obesity Drugs Market by Mechanism of Action
        • 7.4.5.3.3 UAE Anti-Obesity Drugs Market by Route Of Administration
        • 7.4.5.3.4 UAE Anti-Obesity Drugs Market by Distribution Channel
      • 7.4.5.4 Saudi Arabia Anti-Obesity Drugs Market
        • 7.4.5.4.1 Saudi Arabia Anti-Obesity Drugs Market by Drug Type
        • 7.4.5.4.2 Saudi Arabia Anti-Obesity Drugs Market by Mechanism of Action
        • 7.4.5.4.3 Saudi Arabia Anti-Obesity Drugs Market by Route Of Administration
        • 7.4.5.4.4 Saudi Arabia Anti-Obesity Drugs Market by Distribution Channel
      • 7.4.5.5 South Africa Anti-Obesity Drugs Market
        • 7.4.5.5.1 South Africa Anti-Obesity Drugs Market by Drug Type
        • 7.4.5.5.2 South Africa Anti-Obesity Drugs Market by Mechanism of Action
        • 7.4.5.5.3 South Africa Anti-Obesity Drugs Market by Route Of Administration
        • 7.4.5.5.4 South Africa Anti-Obesity Drugs Market by Distribution Channel
      • 7.4.5.6 Nigeria Anti-Obesity Drugs Market
        • 7.4.5.6.1 Nigeria Anti-Obesity Drugs Market by Drug Type
        • 7.4.5.6.2 Nigeria Anti-Obesity Drugs Market by Mechanism of Action
        • 7.4.5.6.3 Nigeria Anti-Obesity Drugs Market by Route Of Administration
        • 7.4.5.6.4 Nigeria Anti-Obesity Drugs Market by Distribution Channel
      • 7.4.5.7 Rest of LAMEA Anti-Obesity Drugs Market
        • 7.4.5.7.1 Rest of LAMEA Anti-Obesity Drugs Market by Drug Type
        • 7.4.5.7.2 Rest of LAMEA Anti-Obesity Drugs Market by Mechanism of Action
        • 7.4.5.7.3 Rest of LAMEA Anti-Obesity Drugs Market by Route Of Administration
        • 7.4.5.7.4 Rest of LAMEA Anti-Obesity Drugs Market by Distribution Channel

Chapter 8. Company Profiles

  • 8.1 Pfizer, Inc.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Regional & Segmental Analysis
    • 8.1.4 Research & Development Expense
  • 8.2 Boehringer Ingelheim International Gmbh
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Regional & Segmental Analysis
    • 8.2.4 Research & Development Expenses
    • 8.2.5 Recent strategies and developments:
      • 8.2.5.1 Partnerships, Collaborations, and Agreements:
  • 8.3 GlaxoSmithKline PLC (GSK)
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Acquisition and Mergers:
  • 8.4 Novo Nordisk A/S
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental & Regional Analysis
    • 8.4.4 Research & Development Expenses
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Approvals and Trials:
  • 8.5 Rhythm Pharmaceuticals, Inc.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Research & Development Expenses
  • 8.6 Gelesis Holdings Inc (PureTech Health)
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Research & Development Expenses
    • 8.6.4 Recent strategies and developments:
      • 8.6.4.1 Partnerships, Collaborations, and Agreements:
      • 8.6.4.2 Approvals and Trials:
  • 8.7 Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
    • 8.7.1 Company Overview
    • 8.7.2 Recent strategies and developments:
      • 8.7.2.1 Acquisition and Mergers:
  • 8.8 Vivus LLC
    • 8.8.1 Company Overview
    • 8.8.2 Recent strategies and developments:
      • 8.8.2.1 Approvals and Trials:
  • 8.9 CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH)
    • 8.9.1 Company Overview
  • 8.10. KVK Tech, Inc.
    • 8.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Global Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 2 Global Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 3 Global Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 4 Global Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 5 Global Prescription Drugs Market by Region, 2019 - 2022, USD Million
  • TABLE 6 Global Prescription Drugs Market by Region, 2023 - 2029, USD Million
  • TABLE 7 Global Over The Counter Drugs Market by Region, 2019 - 2022, USD Million
  • TABLE 8 Global Over The Counter Drugs Market by Region, 2023 - 2029, USD Million
  • TABLE 9 Global Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 10 Global Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 11 Global Centrally Acting Market by Region, 2019 - 2022, USD Million
  • TABLE 12 Global Centrally Acting Market by Region, 2023 - 2029, USD Million
  • TABLE 13 Global Peripherally Acting Market by Region, 2019 - 2022, USD Million
  • TABLE 14 Global Peripherally Acting Market by Region, 2023 - 2029, USD Million
  • TABLE 15 Global Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 16 Global Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 17 Global Oral Route Market by Region, 2019 - 2022, USD Million
  • TABLE 18 Global Oral Route Market by Region, 2023 - 2029, USD Million
  • TABLE 19 Global Subcutaneous Route Market by Region, 2019 - 2022, USD Million
  • TABLE 20 Global Subcutaneous Route Market by Region, 2023 - 2029, USD Million
  • TABLE 21 Global Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 22 Global Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 23 Global Hospital Pharmacies Market by Region, 2019 - 2022, USD Million
  • TABLE 24 Global Hospital Pharmacies Market by Region, 2023 - 2029, USD Million
  • TABLE 25 Global Retail Pharmacies Market by Region, 2019 - 2022, USD Million
  • TABLE 26 Global Retail Pharmacies Market by Region, 2023 - 2029, USD Million
  • TABLE 27 Global Online Pharmacies Market by Region, 2019 - 2022, USD Million
  • TABLE 28 Global Online Pharmacies Market by Region, 2023 - 2029, USD Million
  • TABLE 29 Global Anti-Obesity Drugs Market by Region, 2019 - 2022, USD Million
  • TABLE 30 Global Anti-Obesity Drugs Market by Region, 2023 - 2029, USD Million
  • TABLE 31 North America Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 32 North America Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 33 North America Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 34 North America Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 35 North America Prescription Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 36 North America Prescription Drugs Market by Country, 2023 - 2029, USD Million
  • TABLE 37 North America Over The Counter Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 38 North America Over The Counter Drugs Market by Country, 2023 - 2029, USD Million
  • TABLE 39 North America Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 40 North America Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 41 North America Centrally Acting Market by Country, 2019 - 2022, USD Million
  • TABLE 42 North America Centrally Acting Market by Country, 2023 - 2029, USD Million
  • TABLE 43 North America Peripherally Acting Market by Country, 2019 - 2022, USD Million
  • TABLE 44 North America Peripherally Acting Market by Country, 2023 - 2029, USD Million
  • TABLE 45 North America Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 46 North America Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 47 North America Oral Route Market by Country, 2019 - 2022, USD Million
  • TABLE 48 North America Oral Route Market by Country, 2023 - 2029, USD Million
  • TABLE 49 North America Subcutaneous Route Market by Country, 2019 - 2022, USD Million
  • TABLE 50 North America Subcutaneous Route Market by Country, 2023 - 2029, USD Million
  • TABLE 51 North America Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 52 North America Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 53 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 54 North America Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 55 North America Retail Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 56 North America Retail Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 57 North America Online Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 58 North America Online Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 59 North America Anti-Obesity Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 60 North America Anti-Obesity Drugs Market by Country, 2023 - 2029, USD Million
  • TABLE 61 US Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 62 US Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 63 US Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 64 US Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 65 US Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 66 US Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 67 US Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 68 US Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 69 US Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 70 US Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 71 Canada Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 72 Canada Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 73 Canada Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 74 Canada Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 75 Canada Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 76 Canada Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 77 Canada Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 78 Canada Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 79 Canada Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 80 Canada Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 81 Mexico Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 82 Mexico Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 83 Mexico Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 84 Mexico Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 85 Mexico Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 86 Mexico Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 87 Mexico Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 88 Mexico Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 89 Mexico Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 90 Mexico Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 91 Rest of North America Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 92 Rest of North America Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 93 Rest of North America Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 94 Rest of North America Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 95 Rest of North America Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 96 Rest of North America Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 97 Rest of North America Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 98 Rest of North America Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 99 Rest of North America Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 100 Rest of North America Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 101 Europe Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 102 Europe Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 103 Europe Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 104 Europe Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 105 Europe Prescription Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 106 Europe Prescription Drugs Market by Country, 2023 - 2029, USD Million
  • TABLE 107 Europe Over The Counter Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 108 Europe Over The Counter Drugs Market by Country, 2023 - 2029, USD Million
  • TABLE 109 Europe Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 110 Europe Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 111 Europe Centrally Acting Market by Country, 2019 - 2022, USD Million
  • TABLE 112 Europe Centrally Acting Market by Country, 2023 - 2029, USD Million
  • TABLE 113 Europe Peripherally Acting Market by Country, 2019 - 2022, USD Million
  • TABLE 114 Europe Peripherally Acting Market by Country, 2023 - 2029, USD Million
  • TABLE 115 Europe Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 116 Europe Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 117 Europe Oral Route Market by Country, 2019 - 2022, USD Million
  • TABLE 118 Europe Oral Route Market by Country, 2023 - 2029, USD Million
  • TABLE 119 Europe Subcutaneous Route Market by Country, 2019 - 2022, USD Million
  • TABLE 120 Europe Subcutaneous Route Market by Country, 2023 - 2029, USD Million
  • TABLE 121 Europe Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 122 Europe Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 123 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 124 Europe Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 125 Europe Retail Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 126 Europe Retail Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 127 Europe Online Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 128 Europe Online Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 129 Europe Anti-Obesity Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 130 Europe Anti-Obesity Drugs Market by Country, 2023 - 2029, USD Million
  • TABLE 131 Germany Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 132 Germany Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 133 Germany Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 134 Germany Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 135 Germany Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 136 Germany Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 137 Germany Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 138 Germany Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 139 Germany Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 140 Germany Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 141 UK Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 142 UK Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 143 UK Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 144 UK Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 145 UK Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 146 UK Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 147 UK Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 148 UK Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 149 UK Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 150 UK Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 151 France Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 152 France Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 153 France Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 154 France Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 155 France Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 156 France Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 157 France Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 158 France Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 159 France Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 160 France Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 161 Russia Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 162 Russia Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 163 Russia Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 164 Russia Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 165 Russia Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 166 Russia Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 167 Russia Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 168 Russia Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 169 Russia Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 170 Russia Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 171 Spain Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 172 Spain Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 173 Spain Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 174 Spain Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 175 Spain Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 176 Spain Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 177 Spain Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 178 Spain Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 179 Spain Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 180 Spain Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 181 Italy Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 182 Italy Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 183 Italy Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 184 Italy Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 185 Italy Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 186 Italy Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 187 Italy Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 188 Italy Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 189 Italy Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 190 Italy Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 191 Rest of Europe Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 192 Rest of Europe Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 193 Rest of Europe Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 194 Rest of Europe Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 195 Rest of Europe Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 196 Rest of Europe Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 197 Rest of Europe Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 198 Rest of Europe Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 199 Rest of Europe Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 200 Rest of Europe Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 201 Asia Pacific Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 202 Asia Pacific Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 203 Asia Pacific Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 204 Asia Pacific Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 205 Asia Pacific Prescription Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 206 Asia Pacific Prescription Drugs Market by Country, 2023 - 2029, USD Million
  • TABLE 207 Asia Pacific Over The Counter Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 208 Asia Pacific Over The Counter Drugs Market by Country, 2023 - 2029, USD Million
  • TABLE 209 Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 210 Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 211 Asia Pacific Centrally Acting Market by Country, 2019 - 2022, USD Million
  • TABLE 212 Asia Pacific Centrally Acting Market by Country, 2023 - 2029, USD Million
  • TABLE 213 Asia Pacific Peripherally Acting Market by Country, 2019 - 2022, USD Million
  • TABLE 214 Asia Pacific Peripherally Acting Market by Country, 2023 - 2029, USD Million
  • TABLE 215 Asia Pacific Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 216 Asia Pacific Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 217 Asia Pacific Oral Route Market by Country, 2019 - 2022, USD Million
  • TABLE 218 Asia Pacific Oral Route Market by Country, 2023 - 2029, USD Million
  • TABLE 219 Asia Pacific Subcutaneous Route Market by Country, 2019 - 2022, USD Million
  • TABLE 220 Asia Pacific Subcutaneous Route Market by Country, 2023 - 2029, USD Million
  • TABLE 221 Asia Pacific Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 222 Asia Pacific Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 223 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 224 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 225 Asia Pacific Retail Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 226 Asia Pacific Retail Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 227 Asia Pacific Online Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 228 Asia Pacific Online Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 229 Asia Pacific Anti-Obesity Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 230 Asia Pacific Anti-Obesity Drugs Market by Country, 2023 - 2029, USD Million
  • TABLE 231 China Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 232 China Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 233 China Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 234 China Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 235 China Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 236 China Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 237 China Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 238 China Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 239 China Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 240 China Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 241 Japan Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 242 Japan Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 243 Japan Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 244 Japan Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 245 Japan Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 246 Japan Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 247 Japan Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 248 Japan Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 249 Japan Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 250 Japan Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 251 India Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 252 India Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 253 India Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 254 India Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 255 India Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 256 India Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 257 India Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 258 India Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 259 India Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 260 India Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 261 South Korea Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 262 South Korea Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 263 South Korea Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 264 South Korea Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 265 South Korea Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 266 South Korea Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 267 South Korea Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 268 South Korea Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 269 South Korea Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 270 South Korea Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 271 Singapore Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 272 Singapore Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 273 Singapore Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 274 Singapore Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 275 Singapore Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 276 Singapore Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 277 Singapore Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 278 Singapore Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 279 Singapore Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 280 Singapore Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 281 Malaysia Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 282 Malaysia Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 283 Malaysia Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 284 Malaysia Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 285 Malaysia Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 286 Malaysia Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 287 Malaysia Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 288 Malaysia Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 289 Malaysia Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 290 Malaysia Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 291 Rest of Asia Pacific Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 292 Rest of Asia Pacific Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 293 Rest of Asia Pacific Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 294 Rest of Asia Pacific Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 295 Rest of Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 296 Rest of Asia Pacific Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 297 Rest of Asia Pacific Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 298 Rest of Asia Pacific Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 299 Rest of Asia Pacific Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 300 Rest of Asia Pacific Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 301 LAMEA Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 302 LAMEA Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 303 LAMEA Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 304 LAMEA Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 305 LAMEA Prescription Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 306 LAMEA Prescription Drugs Market by Country, 2023 - 2029, USD Million
  • TABLE 307 LAMEA Over The Counter Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 308 LAMEA Over The Counter Drugs Market by Country, 2023 - 2029, USD Million
  • TABLE 309 LAMEA Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 310 LAMEA Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 311 LAMEA Centrally Acting Market by Country, 2019 - 2022, USD Million
  • TABLE 312 LAMEA Centrally Acting Market by Country, 2023 - 2029, USD Million
  • TABLE 313 LAMEA Peripherally Acting Market by Country, 2019 - 2022, USD Million
  • TABLE 314 LAMEA Peripherally Acting Market by Country, 2023 - 2029, USD Million
  • TABLE 315 LAMEA Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 316 LAMEA Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 317 LAMEA Oral Route Market by Country, 2019 - 2022, USD Million
  • TABLE 318 LAMEA Oral Route Market by Country, 2023 - 2029, USD Million
  • TABLE 319 LAMEA Subcutaneous Route Market by Country, 2019 - 2022, USD Million
  • TABLE 320 LAMEA Subcutaneous Route Market by Country, 2023 - 2029, USD Million
  • TABLE 321 LAMEA Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 322 LAMEA Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 323 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 324 LAMEA Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 325 LAMEA Retail Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 326 LAMEA Retail Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 327 LAMEA Online Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 328 LAMEA Online Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 329 LAMEA Anti-Obesity Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 330 LAMEA Anti-Obesity Drugs Market by Country, 2023 - 2029, USD Million
  • TABLE 331 Brazil Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 332 Brazil Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 333 Brazil Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 334 Brazil Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 335 Brazil Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 336 Brazil Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 337 Brazil Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 338 Brazil Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 339 Brazil Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 340 Brazil Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 341 Argentina Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 342 Argentina Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 343 Argentina Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 344 Argentina Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 345 Argentina Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 346 Argentina Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 347 Argentina Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 348 Argentina Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 349 Argentina Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 350 Argentina Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 351 UAE Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 352 UAE Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 353 UAE Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 354 UAE Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 355 UAE Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 356 UAE Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 357 UAE Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 358 UAE Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 359 UAE Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 360 UAE Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 361 Saudi Arabia Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 362 Saudi Arabia Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 363 Saudi Arabia Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 364 Saudi Arabia Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 365 Saudi Arabia Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 366 Saudi Arabia Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 367 Saudi Arabia Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 368 Saudi Arabia Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 369 Saudi Arabia Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 370 Saudi Arabia Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 371 South Africa Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 372 South Africa Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 373 South Africa Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 374 South Africa Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 375 South Africa Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 376 South Africa Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 377 South Africa Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 378 South Africa Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 379 South Africa Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 380 South Africa Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 381 Nigeria Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 382 Nigeria Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 383 Nigeria Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 384 Nigeria Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 385 Nigeria Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 386 Nigeria Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 387 Nigeria Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 388 Nigeria Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 389 Nigeria Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 390 Nigeria Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 391 Rest of LAMEA Anti-Obesity Drugs Market, 2019 - 2022, USD Million
  • TABLE 392 Rest of LAMEA Anti-Obesity Drugs Market, 2023 - 2029, USD Million
  • TABLE 393 Rest of LAMEA Anti-Obesity Drugs Market by Drug Type, 2019 - 2022, USD Million
  • TABLE 394 Rest of LAMEA Anti-Obesity Drugs Market by Drug Type, 2023 - 2029, USD Million
  • TABLE 395 Rest of LAMEA Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2022, USD Million
  • TABLE 396 Rest of LAMEA Anti-Obesity Drugs Market by Mechanism of Action, 2023 - 2029, USD Million
  • TABLE 397 Rest of LAMEA Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2022, USD Million
  • TABLE 398 Rest of LAMEA Anti-Obesity Drugs Market by Route Of Administration, 2023 - 2029, USD Million
  • TABLE 399 Rest of LAMEA Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 400 Rest of LAMEA Anti-Obesity Drugs Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 401 Key Information - Pfizer, Inc.
  • TABLE 402 Key Information - Boehringer Ingelheim International GmbH
  • TABLE 403 Key Information - GlaxoSmithKline PLC (GSK)
  • TABLE 404 Key information - Novo Nordisk A/S
  • TABLE 405 Key Information - Rhythm Pharmaceuticals, Inc
  • TABLE 406 Key Information - Gelesis Holdings Inc.
  • TABLE 407 Key Information - Currax Pharmaceuticals LLC
  • TABLE 408 Key Information - Vivus LLC
  • TABLE 409 Key Information - CHEPLAPHARM Arzneimittel GmbH
  • TABLE 410 Key Information - KVK Tech, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Anti-Obesity Drugs Market share by Drug Type, 2022
  • FIG 3 Global Anti-Obesity Drugs Market share by Drug Type, 2029
  • FIG 4 Global Anti-Obesity Drugs Market by Drug Type, 2019 - 2029, USD Million
  • FIG 5 Global Anti-Obesity Drugs Market share by Mechanism of Action, 2022
  • FIG 6 Global Anti-Obesity Drugs Market share by Mechanism of Action, 2029
  • FIG 7 Global Anti-Obesity Drugs Market by Mechanism of Action, 2019 - 2029, USD Million
  • FIG 8 Global Anti-Obesity Drugs Market share by Route Of Administration, 2022
  • FIG 9 Global Anti-Obesity Drugs Market share by Route Of Administration, 2029
  • FIG 10 Global Anti-Obesity Drugs Market by Route Of Administration, 2019 - 2029, USD Million
  • FIG 11 Global Anti-Obesity Drugs Market share by Distribution Channel, 2022
  • FIG 12 Global Anti-Obesity Drugs Market share by Distribution Channel, 2029
  • FIG 13 Global Anti-Obesity Drugs Market by Distribution Channel, 2019 - 2029, USD Million
  • FIG 14 Global Anti-Obesity Drugs Market share by Region, 2022
  • FIG 15 Global Anti-Obesity Drugs Market share by Region, 2029
  • FIG 16 Global Anti-Obesity Drugs Market by Region, 2019 - 2029, USD Million